Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans.
- Authors
- Olfson, E; Saccone, N L; Johnson, E O; Chen, L-S; Culverhouse, R; Doheny, K; Foltz, S M; Fox, L; Gogarten, S M; Hartz, S; Hetrick, K; Laurie, C C; Marosy, B; Amin, N; Arnett, D; Barr, R G; Bartz, T M; Bertelsen, S; Borecki, I B; Brown, M R; Chasman, D I; van Duijn, C M; Feitosa, M F; Fox, E R; Franceschini, N; Franco, O H; Grove, M L; Guo, X; Hofman, A; Kardia, S L R; Morrison, A C; Musani, S K; Psaty, B M; Rao, D C; Reiner, A P; Rice, K; Ridker, P M; Rose, L M; Schick, U M; Schwander, K; Uitterlinden, A G; Vojinovic, D; Wang, J-C; Ware, E B; Wilson, G; Yao, J; Zhao, W; Breslau, N; Hatsukami, D; Stitzel, J A; Rice, J; Goate, A; Bierut, L J
- Year
- 2016
- Journal
- Molecular psychiatry
- PMID
- 26239294
- DOI
- 10.1038/mp.2015.105
- PMCID
- PMC4740321
The common nonsynonymous variant rs16969968 in the α5 nicotinic receptor subunit gene (CHRNA5) is the strongest genetic risk factor for nicotine dependence in European Americans and contributes to risk in African Americans. To comprehensively examine whether other CHRNA5 coding variation influences nicotine dependence risk, we performed targeted sequencing on 1582 nicotine-dependent cases (Fagerström Test for Nicotine Dependence score⩾4) and 1238 non-dependent controls, with independent replication of common and low frequency variants using 12 studies with exome chip data. Nicotine dependence was examined using logistic regression with individual common variants (minor allele frequency (MAF)⩾0.05), aggregate low frequency variants (0.05>MAF⩾0.005) and aggregate rare variants (MAF<0.005). Meta-analysis of primary results was performed with replication studies containing 12 174 heavy and 11 290 light smokers. Next-generation sequencing with 180 × coverage identified 24 nonsynonymous variants and 2 frameshift deletions in CHRNA5, including 9 novel variants in the 2820 subjects. Meta-analysis confirmed the risk effect of the only common variant (rs16969968, European ancestry: odds ratio (OR)=1.3, P=3.5 × 10(-11); African ancestry: OR=1.3, P=0.01) and demonstrated that three low frequency variants contributed an independent risk (aggregate term, European ancestry: OR=1.3, P=0.005; African ancestry: OR=1.4, P=0.0006). The remaining 22 rare coding variants were associated with increased risk of nicotine dependence in the European American primary sample (OR=12.9, P=0.01) and in the same risk direction in African Americans (OR=1.5, P=0.37). Our results indicate that common, low frequency and rare CHRNA5 coding variants are independently associated with nicotine dependence risk. These newly identified variants likely influence the risk for smoking-related diseases such as lung cancer.
Protein Schematic of CHRNA5 nonsynonymous and frameshift variants. Bold underline indicates the only common variant (MAF>5%); Bold indicates low frequency variants (5%>MAF≥0.5%); Other variants are rare (MAF<0.5%).
Forest plots showing the primary sample, replication samples, and random effects meta-analyses from Multivariable Model Set 1. (a) rs16969968 in European Americans; (b) aggregate low frequency variant term in European Americans; (c) rs16969968 in African Americans; (d) aggregate low frequency variant term in African Americans.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Disruption of <i>chrna5</i> blunts aversion and adaptive transcriptomic responses to nicotine and alcohol. | Goel T et al. | — | 2026 | → |
| Boosting the Power of Rare Variant Association Studies by Imputation Using Large-scale Sequencing Population. | Dai 戴景岚 J et al. | — | 2025 | → |
| Loci on chromosome 20 interact with rs16969968 to influence cigarettes per day in European ancestry individuals. | Romero Villela PN et al. | — | 2024 | → |
| The genetic landscape of substance use disorders. | Gerring ZF et al. | — | 2024 | → |
| Single nucleotide polymorphisms rs148582811 regulates its host gene <i>ARVCF</i> expression to affect nicotine-associated hippocampus-dependent memory. | Yang Z et al. | — | 2023 | → |
| Transcriptional changes in the rat brain induced by repetitive transcranial magnetic stimulation. | Weiler M et al. | — | 2023 | → |
| Commentary on Chenoweth et al.: Assessing response to interventions for smoking cessation in diverse populations. | Young KA et al. | — | 2022 | → |
| Gene-based association analysis reveals involvement of LAMA5 and cell adhesion pathways in nicotine dependence in African- and European-American samples. | Fan R et al. | — | 2021 | → |
| 2018 Langley Award for Basic Research on Nicotine and Tobacco: Bringing Precision Medicine to Smoking Cessation. | Bierut LJ | — | 2020 | → |
| Genetics of Smoking Behaviors in American Indians. | Henderson JA et al. | — | 2020 | → |
| Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. | Wittenberg RE et al. | — | 2020 | → |
| Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. | Lutz SM et al. | — | 2019 | → |
| Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use. | Brazel DM et al. | — | 2019 | → |
| Impact of single nucleotide polymorphisms on P450 oxidoreductase and peroxisome proliferator-activated receptor alpha on tacrolimus pharmacokinetics in renal transplant recipients. | Si S et al. | — | 2019 | → |
| Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence. | Garcia-Rivas V et al. | — | 2019 | → |
| CHRNA5 and CHRNA3 polymorphism and lung cancer susceptibility in Palestinian population. | Ayesh BM et al. | — | 2018 | → |
| Human Genetics of Addiction: New Insights and Future Directions. | Hancock DB et al. | — | 2018 | → |
| The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings. | Saccone NL et al. | — | 2018 | → |
| Toward the implementation of genomic applications for smoking cessation and smoking-related diseases. | Ramsey AT et al. | — | 2018 | → |
| Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol Dependence. | Clark SL et al. | — | 2017 | → |
| Exome chip meta-analysis elucidates the genetic architecture of rare coding variants in smoking and drinking behavior | Liu DJ et al. | — | 2017 | — |
| Genome-wide meta-analysis identifies a novel susceptibility signal at CACNA2D3 for nicotine dependence. | Yin X et al. | — | 2017 | → |
| Targeted sequencing identifies genetic polymorphisms of flavin-containing monooxygenase genes contributing to susceptibility of nicotine dependence in European American and African American. | Zhang TX et al. | — | 2017 | → |
| African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction. | Levran O et al. | — | 2016 | → |
| Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. | Zanetti KA et al. | — | 2016 | → |
| Genome-wide single nucleotide polymorphism heritability of nicotine dependence as a multidimensional phenotype. | Bidwell LC et al. | — | 2016 | → |
| Hemizygous Deletion on Chromosome 3p26.1 Is Associated with Heavy Smoking among African American Subjects in the COPDGene Study. | Begum F et al. | — | 2016 | → |
| Neurobiology of addiction: a neurocircuitry analysis. | Koob GF et al. | — | 2016 | → |
| Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use. | Melroy-Greif WE et al. | — | 2016 | → |